One such study, using a full Tet2 KO mouse model, suggests a pro‐tumorigenic effect of Tet2 deletion via an IL‐6‐mediated immunosuppressive effect, which promotes tumor growth in models of hepatocellular carcinoma and breast cancer [47]. The gene discussed is TET2; the disease is breast carcinoma.